Merck posts mixed Q1 2026 results as blockbuster drugs drive growth

But acquisition charges drag earnings into loss

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine

Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action

Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies

Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care

Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living

Metropolis Healthcare launches blood-based test for early Alzheimer’s detection

New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence

Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump

Growth was broad-based across segments

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures

Eli Lilly to acquire Kelonia Therapeutics in up to $7 billion deal to advance cancer treatment